Opinion

Video

Recent Medical Advancements: Opportunities and Considerations

An expert discusses the extended form of carbidopa/levodopa (Crexont) for managing OFF episodes, highlighting trial results that show decreased OFF time and increased ON time, as well as the use of subcutaneous loading of medications in Parkinson disease, which was well tolerated with skin issues as the main adverse effects and resulted in increased ON time without worsening dyskinesia.

Related Videos
Fernando L. Pagan, MD
Fernando L. Pagan, MD
5 experts in this video
5 experts in this video
Fernando L. Pagan, MD
© 2025 MJH Life Sciences

All rights reserved.